NCT02171663View on ClinicalTrials.gov

Dose Escalation Study of BIBW 2992 in Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

February 28, 2006

Conditions
Neoplasms
Interventions
DRUG

BIBW 2992

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY